[{"Assets_0_Q3_USD":269264000.0,"CommonStockSharesOutstanding_0_Q3_shares":14211000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":24905000.0,"NetIncomeLoss_1_Q3_USD":7599000.0,"NetIncomeLoss_3_Q3_USD":11004000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":14377000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":14820000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":14237000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":14524000.0,"StockholdersEquity_0_Q3_USD":255265000.0,"EarningsPerShareBasic_1_Q3_USD":0.53,"EarningsPerShareBasic_3_Q3_USD":0.76,"EarningsPerShareDiluted_1_Q3_USD":0.53,"EarningsPerShareDiluted_3_Q3_USD":0.74,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20181026"}]